PremiumCompany AnnouncementsAmaroq updates share capital and voting rights after option exercises5d ago
PremiumCompany AnnouncementsAlvotech’s Entyvio Biosimilar Push Advances as FDA Accepts AVT80 BLA7d ago6KALVO
PremiumRatingsOculis: Advancing Privosegtor in Optic Neuritis and MS Relapses Supports Buy Rating and Unchanged $26 Price Target13d agoOCS
Oculis: Advancing Privosegtor in Optic Neuritis and MS Relapses Supports Buy Rating and Unchanged $26 Price Target
PremiumCompany AnnouncementsAlvotech Strikes $150 Million Biosimilar Deal With Lotus for U.S. and Key Asian Markets16d ago6KALVO
PremiumThe FlyAlvotech enters licensing, commercialization agreement with Lotus Pharmaceutical17d agoALVO
PremiumBlurbsAnalysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Alvotech (ALVO) and Abbott Laboratories (ABT)17d agoABTALVO
Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Alvotech (ALVO) and Abbott Laboratories (ABT)